Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice

Joost H.H.M. van Riel, Maarten L. Donswijk, Christel Brouwer, Winald R. Gerritsen, T.T. Ha Tan-Phan, Paul W.L. Thimister, Walter Noordzij, Erik T. Te Beek, Laurence J.C. van Warmerdam, Andries M. Bergman, Inge M. van Oort, Dirk N.J. Wyndaele and Maarten J. van der Doelen
Journal of Nuclear Medicine May 2025, jnumed.125.269746; DOI: https://doi.org/10.2967/jnumed.125.269746
Joost H.H.M. van Riel
1Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten L. Donswijk
2Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christel Brouwer
3Department of Nuclear Medicine, Catharina Hospital, Eindhoven, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winald R. Gerritsen
4Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T.T. Ha Tan-Phan
5Department of Nuclear Medicine, Frisius Medical Center, Leeuwarden, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul W.L. Thimister
6Department of Nuclear Medicine, Admiraal de Ruyter Hospital, Goes, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Noordzij
7Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik T. Te Beek
8Department of Nuclear Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence J.C. van Warmerdam
9Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andries M. Bergman
10Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inge M. van Oort
1Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk N.J. Wyndaele
3Department of Nuclear Medicine, Catharina Hospital, Eindhoven, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten J. van der Doelen
1Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Login to the site using your SNMMI member credentials

Individuals

Non-Member Login

Login as an individual user

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Joost H.H.M. van Riel, Maarten L. Donswijk, Christel Brouwer, Winald R. Gerritsen, T.T. Ha Tan-Phan, Paul W.L. Thimister, Walter Noordzij, Erik T. Te Beek, Laurence J.C. van Warmerdam, Andries M. Bergman, Inge M. van Oort, Dirk N.J. Wyndaele, Maarten J. van der Doelen
Journal of Nuclear Medicine May 2025, jnumed.125.269746; DOI: 10.2967/jnumed.125.269746

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Joost H.H.M. van Riel, Maarten L. Donswijk, Christel Brouwer, Winald R. Gerritsen, T.T. Ha Tan-Phan, Paul W.L. Thimister, Walter Noordzij, Erik T. Te Beek, Laurence J.C. van Warmerdam, Andries M. Bergman, Inge M. van Oort, Dirk N.J. Wyndaele, Maarten J. van der Doelen
Journal of Nuclear Medicine May 2025, jnumed.125.269746; DOI: 10.2967/jnumed.125.269746
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • [18F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
  • Whole-Body [18F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
  • Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
Show more Clinical Investigation

Similar Articles

Keywords

  • 223Ra-dichloride
  • 223Ra
  • metastatic castration-resistant prostate cancer
  • real-world evidence
  • retreatment
SNMMI

© 2025 SNMMI

Powered by HighWire